Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Daily News

Randomized Trial Supports Using Hearts Donated After Circulatory Death

Caitlin E. Cox

June 19, 2023

Boosting GDMT and Improving Outcomes? No Mean Task After AHF

Shelley Wood

June 01, 2023

Presentation THT 2022

CAD and HFrEF: Mind the Gap

Presenter: Adam DeVore

February 01, 2022

Presentation ACC 2021

Effect of a Hospital and Post-discharge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction

Presenter: Adam DeVore

May 17, 2021

News Daily News

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Michael O'Riordan

August 13, 2020

News Daily News

Missed Opportunities: Many HF Patients Not Tested for CAD

L.A. McKeown

March 20, 2020

News Conference News ACC 2019

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

Michael O'Riordan

March 25, 2019

Presentation ACC 2019

Initiation of Angiotensin-Neprilysin Inhibition after Acute Decompensated Heart Failure: Results of the Open-Label Extension of the PIONEER-HF Trial

Presenter: Adam D. DeVore

March 17, 2019

Advertisement

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Randomized Trial Supports Using Hearts Donated After Circulatory Death

Boosting GDMT and Improving Outcomes? No Mean Task After AHF

CAD and HFrEF: Mind the Gap

Effect of a Hospital and Post-discharge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Missed Opportunities: Many HF Patients Not Tested for CAD

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

Initiation of Angiotensin-Neprilysin Inhibition after Acute Decompensated Heart Failure: Results of the Open-Label Extension of the PIONEER-HF Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content